Track market-moving stories before they get noisy

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.

Zacks Premium also includes the Zacks Style Scores.

What are the Zacks Style Scores? The Zacks Style Scores is a unique set of guidelines that rates stocks based on three popular investing types, and were developed as complementary indicators for the Zacks Rank. This combination helps investors choose securities with the highest chances of beating the market over the next 30 days.

Each stock is given an alphabetic rating of A, B, C, D or F based on their value, growth, and momentum qualities. With this system, an A is better than a B, a B is better than a C, and so on, meaning the better the score, the better chance the stock will outperform.

The Style Scores are broken down into four categories:

Value ScoreValue investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and many other multiples, the Value Style Score identifies the most attractive and most discounted stocks.

Growth ScoreGrowth investors are more concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, the Growth Style Score analyzes characteristics like projected and historic earnings, sales, and cash flow to find stocks that will see sustainable growth over time.

Momentum ScoreMomentum trading is all about taking advantage of upward or downward trends in a stock's price or earnings outlook, and these investors live by the saying "the trend is your friend." The Momentum Style Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings estimates.

VGM ScoreIf you like to use all three kinds of investing, then the VGM Score is for you. It's a combination of all Style Scores, and is an important indicator to use with the Zacks Rank. The VGM Score rates each stock on their shared weighted styles, narrowing down the companies with the most attractive value, best growth forecast, and most promising momentum.

How Style Scores Work with the Zacks Rank The Zacks Rank, which is a proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, to make building a winning portfolio easier.

It's highly successful, with #1 (Strong Buy) stocks producing an unmatched +23.8% average annual return since 1988. That's more than double the S&P 500. But because of the large number of stocks we rate, there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.

This totals more than 800 top-rated stocks, and it can be overwhelming to try and pick the best stocks for you and your portfolio.

That's where the Style Scores come in.

You want to make sure you're buying stocks with the highest likelihood of success, and to do that, you'll need to pick stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you like a stock that only has a #3 (Hold) rank, it should also have Scores of A or B to guarantee as much upside potential as possible.

As mentioned above, the Scores are designed to work with the Zacks Rank, so any change to a company's earnings outlook should be a deciding factor when picking which stocks to buy.

A stock with a #4 (Sell) or #5 (Strong Sell) rating, for instance, even one with Scores of A and B, will still have a declining earnings forecast, and a greater chance its share price will fall too.

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.

Stock to Watch: Cummins (CMI - Free Report) Cummins Inc. is a leading global designer, manufacturer and distributor of diesel and natural gas engines and powertrain-related component products. Powertrain components include fuel systems, turbochargers, transmissions, batteries and electrified power systems, among others. Headquartered in Columbus, IN, the company offers products to original equipment manufacturers (OEMs), distributors and dealers through a network of roughly 650 company-owned and independent distributor facilities in over 19,000 dealer locations in more than 190 countries and territories.

CMI is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.

Additionally, the company could be a top pick for growth investors. CMI has a Growth Style Score of A, forecasting year-over-year earnings growth of 24.6% for the current fiscal year.

Four analysts revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.33 to $29.64 per share. CMI boasts an average earnings surprise of +8.6%.

With a solid Zacks Rank and top-tier Growth and VGM Style Scores, CMI should be on investors' short list.

Bristol Myers Squibb (NYSE: BMY) today presented results from the EXPLORER-LTE cohort of the MAVA-LTE study (NCT03723655) in a late-breaker presentation at the European Society of Cardiology (ESC) Congress 2026 in Munich, Germany. EXPLORER-LTE is the largest and longest evaluation of symptomatic obstructive hypertrophic cardiomyopathy (oHCM) patients treated with Camzyos, the most-studied cardiac myosin inhibitor (CMI) and a standard of care for patients with oHCM in New York Heart Association (NYHA) class II-III. These data add to the understanding that the effects of Camzyos are sustained for up to five years with continuous, consistent treatment. Additional presentations at ESC Congress from COLLIGO-HCM, a global retrospective real-world data study, add to the well-established real-world evidence supporting Camzyos, helping inform treatment decisions for people living with the condition.

“The EXPLORER-LTE data up to five years reflect the sustained and clinically meaningful effects of Camzyos for patients living with symptomatic oHCM,” said Anjali T. Owens, MD, Medical Director of the Center for Inherited Cardiac Disease and an Associate Professor of Medicine in the Perelman School of Medicine at the University of Pennsylvania. “For a chronic, progressive condition that requires ongoing treatment and monitoring, long-term evidence is essential to helping clinicians better understand how a therapy may benefit patients over time.”

EXPLORER-LTE is a single-arm, open-label, dose-blinded extension of the Phase 3 EXPLORER-HCM study, evaluating the long-term safety and efficacy of Camzyos. A total of 231 patients who completed EXPLORER-HCM enrolled in the long-term extension study. A substantial portion of patients experienced sustained and clinically meaningful reduction of left ventricular outflow tract (LVOT) obstruction, improved by at least one NYHA class and experienced notable improvements in echocardiographic measures and biomarkers. No new safety signals were observed that were not observed in the primary EXPLORER-HCM study.

At 252 weeks, Camzyos treatment resulted in mean changes from baseline at initiation of the long-term extension study of -38.7 mm Hg for resting LVOT gradient and -55.6 mm Hg in Valsalva LVOT gradient. Nearly all patients (97.4%) achieved a Valsalva LVOT gradient ≤ 30 mm Hg, which is the threshold for obstruction in patients with oHCM. 69.6% of patients improved by ≥1 NYHA class and 59.2% of patients were asymptomatic. Mean left ventricular ejection fraction (LVEF) decreased by 10.2% and remained within the normal range. Safety findings were consistent with reported results from the primary EXPLORER-HCM study.

Additional data presented at ESC Congress further support Camzyos and our understanding of the impact of oHCM. Two presentations from COLLIGO-HCM, a global retrospective real-world data study, added to the well-established real-world evidence supporting Camzyos in clinical practice, with a real-world effectiveness and safety profile that is consistent across patients, providing symptom improvement and reduction in LVOT obstruction. A complementary analysis of a real-world observational registry study in Germany reinforces the effectiveness of Camzyos across geographic populations, with patients achieving NYHA class reductions consistent with previously reported real-world studies. These findings build on the existing evidence base for Camzyos and reinforce that the improvements seen in clinical trials are also achieved in real-world settings. An additional analysis of a healthcare resource utilization (HCRU) study in Sweden adds to the understanding of the broader disease burden of HCM and oHCM, including the increased impact of oHCM, and emphasizes the importance of accurate diagnosis and consistent care for patients living with oHCM.

“For people living with symptomatic oHCM, long-term and real-world evidence provides greater confidence in treatment decisions and a clearer understanding of what sustained therapy may mean over time,” said Cristian Massacesi, MD, executive vice president, chief medical officer and head of development, Bristol Myers Squibb. “As part of our dedication to advancing cardiovascular research, the data presented at ESC Congress add to the understanding and trust of Camzyos and its role in helping patients manage oHCM, a serious condition affecting daily activities for many patients.”

Camzyos is supported by the largest body of worldwide evidence in the CMI treatment class, reinforcing its role in transforming care for symptomatic oHCM by improving functional capacity and symptoms, allowing patients to be more active in their daily lives.

About EXPLORER-LTE
EXPLORER-LTE, a cohort of the MAVA-LTE study (NCT03723655), is a single-arm, open-label, dose-blinded extension of the Phase 3 EXPLORER-HCM study evaluating the long-term safety and efficacy of Camzyos. A total of 231 patients in the United States, Europe and Israel who completed EXPLORER-HCM enrolled in the long-term extension study.

About CAMZYOS® (mavacamten)
CAMZYOS® (mavacamten) is the most extensively studied cardiac myosin inhibitor (CMI), approved by regulatory bodies in more than 60 countries and regions across five continents worldwide. In the U.S., CAMZYOS is indicated for the treatment of adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (oHCM) to improve functional capacity and symptoms. In the European Union, CAMZYOS is indicated for the treatment of symptomatic (NYHA, class II-III) oHCM in adult patients.

A selective, reversible, allosteric inhibitor of cardiac myosin, CAMZYOS targets hypercontractility, the source of oHCM. Reduction in cardiac contractility with CAMZYOS treatment leads to reduced LVOT obstruction, improved energy consumption, and lower cardiac filling pressures in oHCM patients. These effects have translated to demonstrated symptom improvements in clinical studies for adults with symptomatic oHCM, enabling them to be more active in their daily lives. CAMZYOS can be used with or without background therapies, including for newly diagnosed patients.

CAMZYOS is supported by the largest body of worldwide evidence in the CMI treatment class, with up to five years of follow up across multiple long-term evidence and real-world studies, demonstrating the consistent and sustained benefits of CAMZYOS to improve symptoms and impact cardiac structure. CAMZYOS has been prescribed by more than 5,000 healthcare providers (HCPs) to over 25,000 patients in the U.S. alone.

Bristol Myers Squibb: Changing the Course of Cardiovascular Disease
Bristol Myers Squibb is inspired by a single vision – transforming patients’ lives through science. Cardiovascular disease is the leading cause of death worldwide, and despite major advances in how we prevent and treat it, the human and societal burden continues to worsen over time. Whether a cardiovascular disease that affects millions of people around the world, or a rarer condition, the need is the same: new and better treatment options that allow people to continue to live their fullest lives.

Bristol Myers Squibb is committed to developing new treatments to address the global burden of cardiovascular disease. Building on our 70-year legacy of discovering and delivering paradigm-changing cardiovascular medicines, we are leveraging our experience and expertise, to take cardiovascular research to the next level and delivering meaningful, life‑changing outcomes for patients.

CAMZYOS U.S. IMPORTANT SAFETY INFORMATION

WARNING: RISK OF HEART FAILURE

CAMZYOS reduces left ventricular ejection fraction (LVEF) and can cause heart failure due to systolic dysfunction.

Echocardiogram assessments of LVEF are required prior to and during treatment with CAMZYOS. Initiation of CAMZYOS in patients with LVEF

Concomitant use of CAMZYOS with certain cytochrome P450 inhibitors or discontinuation of certain cytochrome P450 inducers may increase the risk of heart failure due to systolic dysfunction; therefore, the use of CAMZYOS is contraindicated with the following:

Strong CYP2C19 inhibitorsModerate to strong CYP2C19 inducers or moderate to strong CYP3A4 inducersBecause of the risk of heart failure due to systolic dysfunction, CAMZYOS is available only through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called CAMZYOS REMS PROGRAM.

CONTRAINDICATIONS
CAMZYOS is contraindicated with concomitant use of:

Strong CYP2C19 inhibitorsModerate to strong CYP2C19 inducers or moderate to strong CYP3A4 inducersWARNINGS AND PRECAUTIONS
Heart Failure
CAMZYOS reduces systolic contraction and can cause heart failure or significantly reduce ventricular function. Patients who experience a serious intercurrent illness (e.g., serious infection) or arrhythmia (e.g., atrial fibrillation or other uncontrolled tachyarrhythmia) are at greater risk of developing systolic dysfunction and heart failure.

Assess the patient’s clinical status and LVEF prior to and regularly during treatment and adjust the CAMZYOS dose accordingly. New or worsening arrhythmia, dyspnea, chest pain, fatigue, palpitations, leg edema, or elevations in N-terminal pro-B-type natriuretic peptide (NT-proBNP) may be signs and symptoms of heart failure and should also prompt an evaluation of cardiac function.

Asymptomatic LVEF reduction, intercurrent illnesses, and arrhythmias require additional dosing considerations.

Initiation of CAMZYOS in patients with LVEF

CYP450 Drug Interactions Leading to Heart Failure or Loss of Effectiveness
CAMZYOS is primarily metabolized by CYP2C19 and CYP3A4 enzymes. Concomitant use of CAMZYOS and drugs that interact with these enzymes may lead to life-threatening drug interactions such as heart failure or loss of effectiveness.

Advise patients of the potential for drug interactions, including with over-the-counter medications (such as omeprazole, esomeprazole, or cimetidine). Advise patients to inform their healthcare provider of all concomitant products prior to and during CAMZYOS treatment.

CAMZYOS Risk Evaluation and Mitigation Strategy (REMS) Program
CAMZYOS is only available through a restricted program called the CAMZYOS REMS Program because of the risk of heart failure due to systolic dysfunction. Notable requirements of the CAMZYOS REMS Program include the following:

Prescribers must be certified by enrolling in the REMS ProgramPatients must enroll in the REMS Program and comply with ongoing monitoring requirementsPharmacies must be certified by enrolling in the REMS Program and must only dispense to patients who are authorized to receive CAMZYOSWholesalers and distributors must only distribute to certified pharmaciesFurther information is available at www.CAMZYOSREMS.com or by telephone at 1-833-628-7367.

Embryo-Fetal Toxicity
CAMZYOS may cause fetal toxicity when administered to a pregnant female, based on findings in animal studies. Confirm absence of pregnancy in females of reproductive potential prior to treatment and advise patients to use effective contraception during treatment with CAMZYOS and for 4 months after the last dose. Combined hormonal contraceptives (CHCs) containing a combination of ethinyl estradiol and norethindrone may be used with CAMZYOS. However, CAMZYOS may reduce the effectiveness of certain other CHCs. If these CHCs are used, advise patients to add nonhormonal contraception (such as condoms) during concomitant use and for 4 months after the last dose of CAMZYOS.

ADVERSE REACTIONS

In the EXPLORER-HCM trial, adverse reactions occurring in >5% of patients and more commonly in the CAMZYOS group than in the placebo group were dizziness (27% vs 18%) and syncope (6% vs 2%). There were no new adverse reactions identified in VALOR-HCM.

Effects on Systolic Function
In the EXPLORER-HCM trial, mean (SD) resting LVEF was 74% (6) at baseline in both treatment groups. Mean (SD) absolute change from baseline in LVEF was -4% (8) in the CAMZYOS group and 0% (7) in the placebo group over the 30-week treatment period. At Week 38, following an 8-week interruption of trial drug, mean LVEF was similar to baseline for both treatment groups. In the EXPLORER-HCM trial, 7 (6%) patients in the CAMZYOS group and 2 (2%) patients in the placebo group experienced reversible reductions in LVEF

DRUG INTERACTIONS

Potential for Other Drugs to Affect Plasma Concentrations of CAMZYOS
CAMZYOS is primarily metabolized by CYP2C19 and to a lesser extent by CYP3A4 and CYP2C9. Inducers and inhibitors of CYP2C19 and moderate to strong inhibitors or inducers of CYP3A4 may affect the exposures of CAMZYOS.

Impact of Other Drugs on CAMZYOS:

Strong CYP2C19 Inhibitors: Concomitant use increases CAMZYOS exposure, which may increase the risk of heart failure due to systolic dysfunction. Concomitant use is contraindicated.Moderate to Strong CYP2C19 Inducers or Moderate to Strong CYP3A4 Inducers: Concomitant use decreases CAMZYOS exposure, which may reduce CAMZYOS’ efficacy. The risk of heart failure due to systolic dysfunction may increase with discontinuation of these inducers as the levels of induced enzyme normalizes. Concomitant use is contraindicated.Weak CYP2C19 Inhibitors or Moderate CYP3A4 Inhibitors: Concomitant use with a weak CYP2C19 inhibitor or a moderate CYP3A4 inhibitor increases CAMZYOS exposure, which may increase the risk of adverse drug reactions. Initiate CAMZYOS at the recommended starting dose of 5 mg orally once daily in patients who are on stable therapy with a weak CYP2C19 inhibitor or a moderate CYP3A4 inhibitor. Reduce dose of CAMZYOS by one level (ie, 15 to 10 mg, 10 to 5 mg, or 5 to 2.5 mg) in patients who are on CAMZYOS treatment and intend to initiate a weak CYP2C19 inhibitor or a moderate CYP3A4 inhibitor. Schedule clinical and echocardiographic assessment 4 weeks after inhibitor initiation, and do not up-titrate CAMZYOS until 12 weeks after inhibitor initiation. Avoid initiation of concomitant weak CYP2C19 and moderate CYP3A4 inhibitors in patients who are on stable treatment with 2.5 mg of CAMZYOS because a lower dose is not available. For short-term use (eg, 1 week), interrupt CAMZYOS for the duration of treatment with a weak inhibitor of CYP2C19 or a moderate inhibitor of CYP3A4. CAMZYOS may be reinitiated at the previous dose immediately on discontinuation of concomitant therapy.Moderate CYP2C19 Inhibitors or Strong CYP3A4 Inhibitors: Concomitant use with a moderate CYP2C19 inhibitor or strong CYP3A4 inhibitor increases CAMZYOS exposure, which may increase the risk of adverse drug reactions. Discontinuing use of a moderate CYP2C19 inhibitor or strong CYP3A4 inhibitor after long-term concomitant use may decrease CAMZYOS exposure, which may reduce CAMZYOS’ efficacy. Initiate CAMZYOS at a starting dosage of 2.5 mg orally once daily in patients who are on a stable therapy with a moderate CYP2C19 inhibitor or a strong CYP3A4 inhibitor. Reduce dose of CAMZYOS by one level (ie, 15 to 10 mg, 10 to 5 mg, or 5 to 2.5 mg) in patients who are on CAMZYOS and intend to initiate a moderate CYP2C19 inhibitor or a strong CYP3A4 inhibitor. Avoid initiation of concomitant moderate CYP2C19 and strong CYP3A4 inhibitors in patients who are on a stable treatment with 2.5 mg of CAMZYOS because a lower dose is not available. An increase in dose of CAMZYOS may be needed if the moderate inhibitor of CYP2C19 or strong inhibitor of CYP3A4 is discontinued after long-term concomitant use. Monitor for new or worsening symptoms. For short-term use (ie, when CAMZYOS dose modification is not feasible), interrupt CAMZYOS for the duration of treatment with a moderate inhibitor of CYP2C19 or a strong inhibitor of CYP3A4. CAMZYOS may be reinitiated at the previous dose immediately on discontinuation of concomitant therapy.Potential for CAMZYOS to Affect Plasma Concentrations of Other Drugs
CAMZYOS is an inducer of CYP3A4, CYP2C9, and CYP2C19. Concomitant use with CYP3A4, CYP2C9, or CYP2C19 substrates may reduce plasma concentration of these drugs. Closely monitor when CAMZYOS is used with concomitant CYP3A4, CYP2C9, or CYP2C19 substrates unless otherwise recommended in the Prescribing Information.

Certain Combined Hormonal Contraceptives (CHCs): Progestin and ethinyl estradiol are CYP3A4 substrates. Concomitant use of CAMZYOS may decrease exposures of certain progestins, which may lead to contraceptive failure. CHCs containing a combination of ethinyl estradiol and norethindrone may be used with CAMZYOS, but if other CHCs are used, advise patients to add nonhormonal contraception (such as condoms) or use an alternative contraceptive method that is not affected by CYP450 enzyme induction (eg, intrauterine system) during concomitant use and for 4 months after the last dose of CAMZYOS.

Drugs That Reduce Cardiac Contractility
Expect additive negative inotropic effects of CAMZYOS and other drugs that reduce cardiac contractility. Avoid concomitant use of CAMZYOS in patients on disopyramide, ranolazine, verapamil with a beta blocker, or diltiazem with a beta blocker as these medications and combinations increase the risk of left ventricular systolic dysfunction and heart failure symptoms and clinical experience is limited.

If concomitant therapy with a negative inotrope is initiated, or if the dose of a negative inotrope is increased, monitor LVEF closely until stable doses and clinical response have been achieved.

SPECIFIC POPULATIONS

Pregnancy
Based on animal data, CAMZYOS may cause fetal harm when administered to a pregnant female. Advise pregnant females about the potential risk to the fetus with maternal exposure to CAMZYOS during pregnancy. There is a pregnancy safety study for CAMZYOS. If CAMZYOS is administered during pregnancy, or if a patient becomes pregnant while receiving CAMZYOS or within 4 months after the last dose of CAMZYOS, healthcare providers should report CAMZYOS exposure by contacting Bristol Myers Squibb at 1-800-721-5072 or www.bms.com.

Lactation
The presence of CAMZYOS in human or animal milk, the drug’s effects on the breastfed infant, or the effects on milk production are unknown. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for CAMZYOS and any potential adverse effects on the breastfed child from CAMZYOS or from the underlying maternal condition.

Females and Males of Reproductive Potential
Confirm absence of pregnancy in females of reproductive potential prior to initiation of CAMZYOS. Advise females of reproductive potential to use effective contraception during treatment with CAMZYOS and for 4 months after the last dose. CHCs containing a combination of ethinyl estradiol and norethindrone may be used with CAMZYOS. However, CAMZYOS may reduce the effectiveness of certain other CHCs. If these CHCs are used, advise patients to add nonhormonal contraception (such as condoms) or use an alternative contraceptive method during concomitant use and for 4 months after the last dose of CAMZYOS.

Please see U.S. Full Prescribing Information, including Boxed WARNING and Medication Guide.

About Bristol Myers Squibb: Transforming Patients’ Lives Through Science
At Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what’s possible for the future of medicine and the patients we serve. For more information, visit us at BMS.com or follow us on LinkedIn, X, YouTube, Facebook and Instagram.

Cautionary Statement Regarding Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 regarding, among other things, the research, development and commercialization of pharmaceutical products. All statements that are not statements of historical facts are, or may be deemed to be, forward-looking statements. Such forward-looking statements are based on current expectations and projections about our future financial results, goals, plans and objectives and involve inherent risks, assumptions and uncertainties, including internal or external factors that could delay, divert or change any of them in the next several years, that are difficult to predict, may be beyond our control and could cause our future financial results, goals, plans and objectives to differ materially from those expressed in, or implied by, the statements. These risks, assumptions, uncertainties and other factors include, among others, that results of future post-marketing studies will be consistent with the results of this study, that Camzyos (mavacamten), may not be commercially successful, any marketing approvals, if granted, may have significant limitations on their use, and that continued approval of Camzyos may be contingent upon verification and description of clinical benefit in additional confirmatory trials. No forward-looking statement can be guaranteed. It should be noted that acceptance of the application does not change the standards for FDA approval. Forward-looking statements in this press release should be evaluated together with the many risks and uncertainties that affect Bristol Myers Squibb’s business and market, particularly those identified in the cautionary statement and risk factors discussion in Bristol Myers Squibb’s Annual Report on Form 10-K for the year ended December 31, 2025, as updated by our subsequent Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other filings with the Securities and Exchange Commission. The forward-looking statements included in this document are made only as of the date of this document and except as otherwise required by applicable law, Bristol Myers Squibb undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, changed circumstances or otherwise.

corporate financial-news

View source version on businesswire.com: https://www.businesswire.com/news/home/20260826397542/en/

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.

Zacks Premium includes access to the Zacks Style Scores as well.

What are the Zacks Style Scores? The Zacks Style Scores, developed alongside the Zacks Rank, are complementary indicators that rate stocks based on three widely-followed investing methodologies; they also help investors pick stocks with the best chances of beating the market over the next 30 days.

Each stock is assigned a rating of A, B, C, D, or F based on their value, growth, and momentum characteristics. Just like in school, an A is better than a B, a B is better than a C, and so on -- that means the better the score, the better chance the stock will outperform.

The Style Scores are broken down into four categories:

Value ScoreFinding good stocks at good prices, and discovering which companies are trading under their true value, are what value investors like to focus on. So, the Value Style Score takes into account ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to highlight the most attractive and discounted stocks.

Growth ScoreGrowth investors are more concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, the Growth Style Score analyzes characteristics like projected and historic earnings, sales, and cash flow to find stocks that will see sustainable growth over time.

Momentum ScoreMomentum traders and investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks.

VGM ScoreIf you like to use all three kinds of investing, then the VGM Score is for you. It's a combination of all Style Scores, and is an important indicator to use with the Zacks Rank. The VGM Score rates each stock on their shared weighted styles, narrowing down the companies with the most attractive value, best growth forecast, and most promising momentum.

How Style Scores Work with the Zacks Rank The Zacks Rank is a proprietary stock-rating model that harnesses the power of earnings estimate revisions, or changes to a company's earnings expectations, to help investors build a successful portfolio.

Investors can count on the Zacks Rank's success, with #1 (Strong Buy) stocks producing an unmatched +23.8% average annual return since 1988, more than double the S&P 500's performance. But the model rates a large number of stocks, and there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.

But it can feel overwhelming to pick the right stocks for you and your investing goals with over 800 top-rated stocks to choose from.

That's where the Style Scores come in.

To have the best chance of big returns, you'll want to always consider stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B, which will give you the highest probability of success. If you're looking at stocks with a #3 (Hold) rank, it's important they have Scores of A or B as well to ensure as much upside potential as possible.

The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank.

Here's an example: a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one with Style Scores of A and B, still has a downward-trending earnings outlook, and a bigger chance its share price will decrease too.

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.

Stock to Watch: Cummins (CMI - Free Report) Cummins Inc. is a leading global designer, manufacturer and distributor of diesel and natural gas engines and powertrain-related component products. Powertrain components include fuel systems, turbochargers, transmissions, batteries and electrified power systems, among others. Headquartered in Columbus, IN, the company offers products to original equipment manufacturers (OEMs), distributors and dealers through a network of roughly 650 company-owned and independent distributor facilities in over 19,000 dealer locations in more than 190 countries and territories.

CMI is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.

It also boasts a Value Style Score of B thanks to attractive valuation metrics like a forward P/E ratio of 19.83; value investors should take notice.

For fiscal 2026, four analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.33 to $29.64 per share. CMI boasts an average earnings surprise of +8.6%.

With a solid Zacks Rank and top-tier Value and VGM Style Scores, CMI should be on investors' short list.

Data centers can't simply shut down when the grid fails. That's why these facilities require enormous backup generators capable of providing electricity almost immediately.

That's exactly what Cummins (CMI -0.51%) provides. The company best known for diesel engines also happens to be a major supplier of backup power for data centers, and that's becoming increasingly valuable as AI spending soars.

S&P Global estimates that Alphabet (GOOG +1.22%)(GOOGL +1.37%), Amazon (AMZN -0.39%), Meta Platforms (META +0.70%), Microsoft (MSFT +0.34%), and Oracle (ORCL +3.38%) will collectively spend approximately $750 billion on capital expenditures in 2026, equal to about 38% of their combined revenue. Much of that spending is being driven by AI and the data centers required to support it. Cummins is already cashing in.

Not a one-quarter phenomenon During the second quarter, Cummins' Power Systems sales jumped 19% year over year, driven by strong global demand for data center power equipment. Segment EBITDA margin also reached 24.5%, up from 22.8% a year earlier.

This isn't just a one-quarter phenomenon, either. Cummins says its growth in the data center market is being driven partly by sales of diesel and natural gas generator sets used for backup power, as AI racks are becoming more power-hungry.

Cummins says traditional data center racks averaged around 12 kilowatts, while next-generation AI racks could reach 600 kilowatts or more. The more electricity these facilities consume, the more backup generating capacity they need when the grid goes down.

Image source: Getty Images.

Cummins is moving beyond backup power Cummins is also starting to sell generators that don't simply wait around for an outage. In June, the company announced an agreement with Circe Energy to provide high-powered natural gas generators for a large high-performance-computing data center in West Texas. Those generators will be part of a behind-the-meter microgrid providing primary power, with deliveries scheduled from 2026 through 2030.

That's a huge opportunity. Grid connections can take years, and AI developers don't necessarily want to wait. Cummins can now potentially sell generators both as emergency backup and as a bridge, or even alternative, to traditional grid power.

Today's Change

(

-0.51

%) $

-3.04

Current Price

$

588.00

An industrial stock riding the AI boom Make no mistake: Cummins isn't an AI pure play. Trucks, engines, components, and industrial equipment remain major parts of its business. But AI is also serving as a catalyst for a new form of revenue generation for the company.

The truth is, you don't have to bet on which AI model wins or which semiconductor eventually replaces today's graphics processing units. The world's largest technology companies are spending hundreds of billions of dollars building computing infrastructure, and every one of those facilities requires reliable backup power. Cummins already sells the equipment that provides it. It's pretty much a no-brainer.

If hyperscalers really spend around $750 billion this year, Cummins only needs a small piece of that infrastructure build-out for data centers to become a much bigger part of its business.

Jeff Siegel has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Alphabet, Amazon, Cummins, Meta Platforms, Microsoft, and Oracle. The Motley Fool has a disclosure policy.

Allworth Financial LP purchased a new stake in shares of Cummins Inc. (NYSE:CMI – Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 30,969 shares of the company’s stock, valued at approximately $22,087,000.

Several other institutional investors and hedge funds have also bought and sold shares of CMI. Juno Financial Group LLC bought a new position in shares of Cummins during the fourth quarter valued at approximately $883,000. Truist Financial Corp boosted its position in shares of Cummins by 4.8% in the 4th quarter. Truist Financial Corp now owns 64,005 shares of the company’s stock worth $32,671,000 after purchasing an additional 2,951 shares in the last quarter. Kepler Cheuvreux Suisse SA bought a new stake in shares of Cummins in the 4th quarter worth approximately $7,869,000. Westfield Capital Management Co. LP purchased a new stake in shares of Cummins in the 4th quarter worth approximately $7,797,000. Finally, Comprehensive Financial Consultants Institutional Inc. increased its position in Cummins by 643.0% during the 4th quarter. Comprehensive Financial Consultants Institutional Inc. now owns 7,311 shares of the company’s stock valued at $3,732,000 after buying an additional 6,327 shares in the last quarter. 83.46% of the stock is currently owned by hedge funds and other institutional investors.

Cummins Price Performance NYSE CMI opened at $593.12 on Friday. Cummins Inc. has a one year low of $389.52 and a one year high of $737.76. The stock has a 50-day moving average of $662.30 and a 200 day moving average of $628.59. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.13 and a current ratio of 1.73. The company has a market capitalization of $81.65 billion, a price-to-earnings ratio of 30.31, a PEG ratio of 1.45 and a beta of 1.24.

Cummins (NYSE:CMI – Get Free Report) last posted its earnings results on Tuesday, August 4th. The company reported $6.73 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.21 by ($0.48). Cummins had a net margin of 7.82% and a return on equity of 25.29%. The company had revenue of $9.46 billion for the quarter, compared to the consensus estimate of $9.33 billion. During the same quarter in the prior year, the company posted $6.43 EPS. Cummins’s revenue was up 9.4% on a year-over-year basis. On average, sell-side analysts forecast that Cummins Inc. will post 30.06 EPS for the current year. Cummins Increases Dividend The business also recently announced a quarterly dividend, which will be paid on Thursday, September 3rd. Shareholders of record on Friday, August 21st will be given a $2.20 dividend. This is a boost from Cummins’s previous quarterly dividend of $2.00. The ex-dividend date of this dividend is Friday, August 21st. This represents a $8.80 dividend on an annualized basis and a yield of 1.5%. Cummins’s payout ratio is presently 40.88%.

Analyst Upgrades and Downgrades A number of research analysts have issued reports on CMI shares. Argus lifted their price objective on Cummins from $696.00 to $770.00 and gave the company a “buy” rating in a research note on Monday, June 1st. Sanford C. Bernstein restated a “market perform” rating and set a $700.00 price target on shares of Cummins in a report on Wednesday, August 5th. UBS Group lowered their price target on Cummins from $850.00 to $835.00 and set a “buy” rating for the company in a research report on Wednesday, August 5th. Citigroup upped their price target on shares of Cummins from $770.00 to $790.00 and gave the stock a “buy” rating in a research note on Tuesday, July 14th. Finally, Truist Financial set a $894.00 price objective on shares of Cummins in a research report on Wednesday, August 5th. Eleven analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, Cummins has an average rating of “Moderate Buy” and an average target price of $745.64.

View Our Latest Analysis on Cummins

About Cummins (Free Report)

Cummins Inc (NYSE: CMI) is a global power technology company that designs, manufactures, distributes and services a broad portfolio of diesel and natural gas engines, electrified powertrains, power generation systems and related components. Founded in 1919 and headquartered in Columbus, Indiana, Cummins has grown into one of the world’s leading suppliers of internal combustion engines and a provider of technologies that reduce emissions and improve fuel efficiency.

The company’s product lineup includes heavy-, medium- and light-duty engines for on-highway and off-highway applications, generator sets and power systems for commercial and industrial use, and key engine components such as turbochargers, fuel systems, air handling, filtration and aftertreatment solutions.

Further Reading Five stocks we like better than Cummins 3 Energy Stocks Raising Dividends as the Sector Surges 5 Reasons the S&P 500 Could Keep Rallying Through Year-End Walmart’s Post-Earnings Drop Could Be a Buying Opportunity The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future

Receive News & Ratings for Cummins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cummins and related companies with MarketBeat.com's FREE daily email newsletter.

On August 18, 2026, we conducted a discounted cash flow (DCF) analysis for Cummins Inc (CMI) amidst a backdrop of notable price performance. The stock has seen

Posted by Defense World Staff on Aug 16th, 2026

Bellars Harris Wealth Management LLC purchased a new position in shares of Cummins Inc. (NYSE:CMI – Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 13,609 shares of the company’s stock, valued at approximately $9,706,000. Cummins makes up 2.0% of Bellars Harris Wealth Management LLC’s portfolio, making the stock its 13th biggest position.

A number of other institutional investors have also made changes to their positions in CMI. Brighton Jones LLC grew its position in Cummins by 4.1% in the fourth quarter. Brighton Jones LLC now owns 2,112 shares of the company’s stock valued at $736,000 after purchasing an additional 83 shares in the last quarter. Intech Investment Management LLC grew its holdings in shares of Cummins by 40.8% in the 1st quarter. Intech Investment Management LLC now owns 3,956 shares of the company’s stock valued at $1,240,000 after acquiring an additional 1,146 shares in the last quarter. Treasurer of the State of North Carolina increased its position in shares of Cummins by 2.8% in the second quarter. Treasurer of the State of North Carolina now owns 64,289 shares of the company’s stock valued at $21,055,000 after acquiring an additional 1,759 shares during the last quarter. ICW Investment Advisors LLC bought a new stake in Cummins during the second quarter worth about $225,000. Finally, Osterweis Capital Management Inc. acquired a new position in Cummins during the second quarter valued at approximately $31,000. Institutional investors own 83.46% of the company’s stock.

Cummins Stock Performance NYSE CMI opened at $631.81 on Friday. The stock has a market cap of $86.98 billion, a PE ratio of 32.28, a P/E/G ratio of 1.50 and a beta of 1.24. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.13 and a current ratio of 1.73. The firm has a 50-day moving average of $665.58 and a 200-day moving average of $627.15. Cummins Inc. has a 52-week low of $389.52 and a 52-week high of $737.76.

Cummins (NYSE:CMI – Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The company reported $6.73 earnings per share for the quarter, missing the consensus estimate of $7.21 by ($0.48). The company had revenue of $9.46 billion during the quarter, compared to the consensus estimate of $9.33 billion. Cummins had a net margin of 7.82% and a return on equity of 25.29%. The firm’s revenue was up 9.4% compared to the same quarter last year. During the same period in the prior year, the company earned $6.43 earnings per share. On average, sell-side analysts anticipate that Cummins Inc. will post 30.15 EPS for the current year.

Cummins Increases Dividend The company also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Friday, August 21st will be issued a dividend of $2.20 per share. This represents a $8.80 annualized dividend and a yield of 1.4%. The ex-dividend date of this dividend is Friday, August 21st. This is an increase from Cummins’s previous quarterly dividend of $2.00. Cummins’s payout ratio is 40.88%.

Analysts Set New Price Targets Several research firms have weighed in on CMI. Wells Fargo & Company boosted their price target on Cummins from $794.00 to $874.00 and gave the stock an “overweight” rating in a research report on Wednesday, June 17th. Robert W. Baird set a $700.00 target price on shares of Cummins in a report on Wednesday, May 6th. UBS Group cut their price target on shares of Cummins from $850.00 to $835.00 and set a “buy” rating for the company in a research note on Wednesday, August 5th. Sanford C. Bernstein restated a “market perform” rating and set a $700.00 price objective on shares of Cummins in a research note on Wednesday, August 5th. Finally, JPMorgan Chase & Co. raised their target price on shares of Cummins from $600.00 to $725.00 and gave the company a “neutral” rating in a research note on Wednesday, May 6th. Eleven analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $745.64.

Read Our Latest Stock Analysis on CMI

About Cummins (Free Report)

Cummins Inc (NYSE: CMI) is a global power technology company that designs, manufactures, distributes and services a broad portfolio of diesel and natural gas engines, electrified powertrains, power generation systems and related components. Founded in 1919 and headquartered in Columbus, Indiana, Cummins has grown into one of the world’s leading suppliers of internal combustion engines and a provider of technologies that reduce emissions and improve fuel efficiency.

The company’s product lineup includes heavy-, medium- and light-duty engines for on-highway and off-highway applications, generator sets and power systems for commercial and industrial use, and key engine components such as turbochargers, fuel systems, air handling, filtration and aftertreatment solutions.

Read More Five stocks we like better than Cummins Is Best Buy the AI Winner Hiding in the Electronics Aisle? Applied Materials Beat Everything but Wall Street’s Expectations for Margins Back From Orbit, Intuitive Machines’ Share Price Enters the Buy Zone Texas Roadhouse and Brinker International Have the Recipe Rivals Are Missing Want to see what other hedge funds are holding CMI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cummins Inc. (NYSE:CMI – Free Report).

Receive News & Ratings for Cummins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cummins and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEBLB&B Advisors LLC Grows Stake in Capital One Financial Corporation $COF

NEXT HEADLINE »Bellars Harris Wealth Management LLC Takes Position in Bank of New York Mellon Corporation $BNY

Posted by Defense World Staff on Aug 10th, 2026

Atlas Brown Inc. cut its stake in shares of Cummins Inc. (NYSE:CMI – Free Report) by 38.6% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,169 shares of the company’s stock after selling 1,995 shares during the quarter. Atlas Brown Inc.’s holdings in Cummins were worth $2,260,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CMI. Brighton Jones LLC increased its position in shares of Cummins by 4.1% during the 4th quarter. Brighton Jones LLC now owns 2,112 shares of the company’s stock valued at $736,000 after purchasing an additional 83 shares during the last quarter. Intech Investment Management LLC lifted its position in Cummins by 40.8% in the 1st quarter. Intech Investment Management LLC now owns 3,956 shares of the company’s stock worth $1,240,000 after buying an additional 1,146 shares during the last quarter. Treasurer of the State of North Carolina boosted its stake in Cummins by 2.8% in the second quarter. Treasurer of the State of North Carolina now owns 64,289 shares of the company’s stock worth $21,055,000 after buying an additional 1,759 shares in the last quarter. ICW Investment Advisors LLC purchased a new stake in Cummins in the second quarter worth approximately $225,000. Finally, Osterweis Capital Management Inc. bought a new position in Cummins during the second quarter valued at approximately $31,000. 83.46% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling In related news, VP Donald G. Jackson sold 730 shares of the company’s stock in a transaction that occurred on Thursday, May 14th. The stock was sold at an average price of $710.92, for a total transaction of $518,971.60. Following the completion of the transaction, the vice president owned 8,316 shares in the company, valued at $5,912,010.72. This represents a 8.07% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Jennifer Mary Bush sold 5,000 shares of the firm’s stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $696.21, for a total value of $3,481,050.00. Following the completion of the sale, the vice president directly owned 11,986 shares of the company’s stock, valued at $8,344,773.06. The trade was a 29.44% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.30% of the stock is owned by corporate insiders.

Cummins Stock Down 0.0% NYSE CMI opened at $644.21 on Monday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.73 and a quick ratio of 1.13. The stock has a market capitalization of $88.68 billion, a PE ratio of 32.92, a PEG ratio of 1.55 and a beta of 1.24. Cummins Inc. has a 1 year low of $383.90 and a 1 year high of $737.76. The business’s 50-day moving average is $668.83 and its 200 day moving average is $625.48.

Cummins (NYSE:CMI – Get Free Report) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $6.73 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.21 by ($0.48). The business had revenue of $9.46 billion for the quarter, compared to analysts’ expectations of $9.33 billion. Cummins had a net margin of 7.82% and a return on equity of 25.29%. The firm’s revenue for the quarter was up 9.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $6.43 EPS. Sell-side analysts forecast that Cummins Inc. will post 29.73 earnings per share for the current year.

Cummins Increases Dividend The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 3rd. Stockholders of record on Friday, August 21st will be paid a dividend of $2.20 per share. This represents a $8.80 annualized dividend and a dividend yield of 1.4%. This is a boost from Cummins’s previous quarterly dividend of $2.00. The ex-dividend date of this dividend is Friday, August 21st. Cummins’s payout ratio is presently 40.88%.

Analyst Ratings Changes A number of equities research analysts have recently weighed in on CMI shares. Sanford C. Bernstein restated a “market perform” rating and issued a $700.00 price objective on shares of Cummins in a report on Wednesday. Evercore reaffirmed an “outperform” rating and set a $845.00 target price on shares of Cummins in a report on Monday, May 11th. JPMorgan Chase & Co. lifted their target price on shares of Cummins from $600.00 to $725.00 and gave the stock a “neutral” rating in a research report on Wednesday, May 6th. Raymond James Financial boosted their price target on shares of Cummins from $675.00 to $745.00 and gave the stock an “outperform” rating in a research note on Tuesday, May 26th. Finally, Zacks Research downgraded Cummins from a “strong-buy” rating to a “hold” rating in a report on Monday, July 13th. Eleven equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $745.64.

Read Our Latest Analysis on CMI

About Cummins (Free Report)

Cummins Inc (NYSE: CMI) is a global power technology company that designs, manufactures, distributes and services a broad portfolio of diesel and natural gas engines, electrified powertrains, power generation systems and related components. Founded in 1919 and headquartered in Columbus, Indiana, Cummins has grown into one of the world’s leading suppliers of internal combustion engines and a provider of technologies that reduce emissions and improve fuel efficiency.

The company’s product lineup includes heavy-, medium- and light-duty engines for on-highway and off-highway applications, generator sets and power systems for commercial and industrial use, and key engine components such as turbochargers, fuel systems, air handling, filtration and aftertreatment solutions.

See Also Five stocks we like better than Cummins Albemarle’s Blowout Quarter Shows Why Lithium Still Matters Can DICK’S Turn Foot Locker Into a Winner? Why Dutch Bros Plunged Despite a Q2 Earnings Beat and Record Revenue Take-Two’s Q1 Results Leave GTA 6 Bulls Stuck in the Fog of War Want to see what other hedge funds are holding CMI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cummins Inc. (NYSE:CMI – Free Report).

Receive News & Ratings for Cummins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cummins and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEMoonpig Group (LON:MOON) Reaches New 1-Year High – Time to Buy?

NEXT HEADLINE »Bytes Technology Group (LON:BYIT) Hits New 52-Week High – Should You Buy?

Cummins delivered mixed Q2 results, with revenue beats but EPS misses and soft profitability outside power systems. CMI raised full-year revenue guidance to 10%-13% growth and narrowed EBITDA margin outlook to 18%-18.5%, citing data center and China construction demand. Data center power generation and a recovering truck market are set to drive multi-year growth, offsetting segment softness.

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.

The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.

Zacks Premium also includes the Zacks Style Scores.

What are the Zacks Style Scores? The Zacks Style Scores, developed alongside the Zacks Rank, are complementary indicators that rate stocks based on three widely-followed investing methodologies; they also help investors pick stocks with the best chances of beating the market over the next 30 days.

Each stock is given an alphabetic rating of A, B, C, D or F based on their value, growth, and momentum qualities. With this system, an A is better than a B, a B is better than a C, and so on, meaning the better the score, the better chance the stock will outperform.

The Style Scores are broken down into four categories:

Value ScoreFinding good stocks at good prices, and discovering which companies are trading under their true value, are what value investors like to focus on. So, the Value Style Score takes into account ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to highlight the most attractive and discounted stocks.

Growth ScoreGrowth investors, on the other hand, are more concerned with a company's financial strength and health, and its future outlook. The Growth Style Score examines things like projected and historic earnings, sales, and cash flow to find stocks that will experience sustainable growth over time.

Momentum ScoreMomentum traders and investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks.

VGM ScoreWhat if you like to use all three types of investing? The VGM Score is a combination of all Style Scores, making it one of the most comprehensive indicators to use with the Zacks Rank. It rates each stock on their combined weighted styles, which helps narrow down the companies with the most attractive value, best growth forecast, and most promising momentum.

How Style Scores Work with the Zacks Rank A proprietary stock-rating model, the Zacks Rank utilizes the power of earnings estimate revisions, or changes to a company's earnings outlook, to help investors create a successful portfolio.

Investors can count on the Zacks Rank's success, with #1 (Strong Buy) stocks producing an unmatched +23.94% average annual return since 1988, more than double the S&P 500's performance. But the model rates a large number of stocks, and there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.

But it can feel overwhelming to pick the right stocks for you and your investing goals with over 800 top-rated stocks to choose from.

That's where the Style Scores come in.

You want to make sure you're buying stocks with the highest likelihood of success, and to do that, you'll need to pick stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you like a stock that only has a #3 (Hold) rank, it should also have Scores of A or B to guarantee as much upside potential as possible.

As mentioned above, the Scores are designed to work with the Zacks Rank, so any change to a company's earnings outlook should be a deciding factor when picking which stocks to buy.

For instance, a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one that boasts Scores of A and B, still has a downward-trending earnings forecast, and a much greater likelihood its share price will decline as well.

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.

Stock to Watch: Cummins (CMI - Free Report) Cummins Inc. is a leading global designer, manufacturer and distributor of diesel and natural gas engines and powertrain-related component products. Powertrain components include fuel systems, turbochargers, transmissions, batteries and electrified power systems, among others. Headquartered in Columbus, IN, the company offers products to original equipment manufacturers (OEMs), distributors and dealers through a network of roughly 650 company-owned and independent distributor facilities in over 19,000 dealer locations in more than 190 countries and territories.

CMI is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.

Additionally, the company could be a top pick for growth investors. CMI has a Growth Style Score of B, forecasting year-over-year earnings growth of 23.6% for the current fiscal year.

Four analysts revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.10 to $29.39 per share. CMI boasts an average earnings surprise of +8.6%.

With a solid Zacks Rank and top-tier Growth and VGM Style Scores, CMI should be on investors' short list.

Posted by Defense World Staff on Aug 5th, 2026

Anderson Hoagland & Co. raised its position in shares of Cummins Inc. (NYSE:CMI – Free Report) by 26.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 23,908 shares of the company’s  stock after buying an additional 4,934 shares during the period. Cummins comprises 1.3% of Anderson Hoagland & Co.’s portfolio, making the stock its 21st biggest position. Anderson Hoagland & Co.’s holdings in Cummins were worth $17,051,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of CMI. Activest Wealth Management increased its position in Cummins by 537.5% in the 4th quarter. Activest Wealth Management now owns 51 shares of the company’s stock valued at $26,000 after acquiring an additional 43 shares in the last quarter. Cedar Mountain Advisors LLC lifted its position in Cummins by 1,500.0% during the 1st quarter. Cedar Mountain Advisors LLC now owns 48 shares of the company’s stock valued at $26,000 after purchasing an additional 45 shares during the period. Wellington Shields Capital Management LLC bought a new position in shares of Cummins in the 4th quarter valued at about $27,000. Key Financial Inc boosted its stake in shares of Cummins by 62.5% in the 1st quarter. Key Financial Inc now owns 52 shares of the company’s stock valued at $28,000 after purchasing an additional 20 shares during the last quarter. Finally, Birchwood Financial Partners Inc. acquired a new stake in shares of Cummins during the 4th quarter worth approximately $28,000. Institutional investors own 83.46% of the company’s stock.

Key Headlines Impacting Cummins Here are the key  news stories impacting Cummins this week:

Positive Sentiment: Cummins reported second-quarter revenue of approximately $9.46 billion, ahead of the $9.33 billion consensus estimate and up 9.4% year over year. The company cited record demand for standby power used by data centers and improving North American truck markets. Cummins Reports Strong Second Quarter 2026 Results; Raises Full-Year Outlook Positive Sentiment: The company raised its full-year 2026 outlook and provided revenue guidance of $37 billion to $38 billion, broadly consistent with analysts’ expectations. Management’s comments suggest continued momentum from data-center infrastructure spending and commercial  vehicle demand. Cummins Raises Outlook as Profit, Sales Climb Negative Sentiment: Adjusted earnings were reported at roughly $6.73 to $6.94 per share, depending on the source, below consensus estimates ranging from $7.21 to $7.33. The earnings miss appears to have outweighed the revenue beat and raised guidance, increasing concern about margins and near-term profitability. Cummins misses quarterly profit estimates despite strong generator demand Cummins Stock Down 1.8% Discover more

Air defense systems

military

Stocks & Bonds

Engine manufacturing technologies

Autos & Vehicles

Shares of NYSE:CMI opened at $637.42 on Wednesday. The company has a 50 day moving average price of $669.66 and a two-hundred day moving average price of $624.04. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.11 and a current ratio of 1.71. The company has a market capitalization of $87.96 billion, a PE ratio of 33.08, a PEG ratio of 1.58 and a beta of 1.24. Cummins Inc. has a 52 week low of $364.14 and a 52 week high of $737.76.

Cummins (NYSE:CMI – Get Free Report) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $6.73 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.21 by ($0.48). The firm had revenue of $9.46 billion during the quarter, compared to analyst estimates of $9.33 billion. Cummins had a net margin of 7.89% and a return on equity of 25.25%. Cummins’s quarterly revenue was up 9.4% on a year-over-year basis. During the same period last year, the firm earned $6.43 EPS. Analysts forecast that Cummins Inc. will post 29.39 earnings per share for the current year.

Cummins Increases Dividend The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Shareholders of record on Friday, August 21st will be issued a $2.20 dividend. This represents a $8.80 annualized dividend and a dividend yield of 1.4%. This is an increase from Cummins’s previous quarterly dividend of $2.00. The ex-dividend date is Friday, August 21st. Cummins’s dividend payout ratio is currently 41.52%.

Insider Buying and Selling In related news, insider Brett Michael Merritt sold 701 shares of the  stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $688.75, for a total transaction of $482,813.75. Following the completion of the sale, the insider directly owned 10,404 shares of the company’s stock, valued at approximately $7,165,755. This represents a 6.31% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Donald G. Jackson sold 730 shares of the firm’s stock in a transaction that occurred on Thursday, May 14th. The stock was sold at an average price of $710.92, for a total transaction of $518,971.60. Following the sale, the vice president owned 8,316 shares in the company, valued at $5,912,010.72. This trade represents a 8.07% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 13,579 shares of company stock valued at $9,377,684. 0.30% of the stock is owned by company insiders.

Wall Street Analyst Weigh In A number of research firms recently weighed in on CMI. Weiss Ratings downgraded shares of Cummins from a “buy (b)” rating to a “buy (b-)” rating in a research note on Wednesday, May 6th. Morgan Stanley lifted their target price on shares of Cummins from $752.00 to $761.00 and gave the stock an “overweight” rating in a report on Friday, July 17th. Raymond James Financial upped their target price on shares of Cummins from $675.00 to $745.00 and gave the company an “outperform” rating in a research report on Tuesday, May 26th. Zacks Research downgraded Cummins from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 13th. Finally, JPMorgan Chase & Co. raised their price target on Cummins from $600.00 to $725.00 and gave the stock a “neutral” rating in a research report on Wednesday, May 6th. Eleven investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, Cummins currently has a consensus rating of “Moderate Buy” and a consensus price target of $740.07.

View Our Latest Analysis on Cummins

About Cummins (Free Report)

Cummins Inc (NYSE: CMI) is a global power technology company that designs, manufactures, distributes and services a broad portfolio of diesel and natural gas engines, electrified powertrains, power generation systems and related components. Founded in 1919 and headquartered in Columbus, Indiana, Cummins has grown into one of the world’s leading suppliers of internal combustion engines and a provider of technologies that reduce emissions and improve fuel efficiency.

The company’s product lineup includes heavy-, medium- and light-duty engines for on-highway and off-highway applications, generator sets and power systems for commercial and industrial use, and key engine components such as turbochargers, fuel systems, air handling, filtration and aftertreatment solutions.

See Also Five stocks we like better than Cummins System Upgrade: First Internet Bancorp Options Surge AI Security Breaches Raise New Risks for Microsoft and Amazon’s Agent Push The AI Chip Blockade Is Creating a Shadow Market Grab Holdings Stock Forms Bottom After Strong Beat-and-Raise Quarter Want to see what other hedge funds are holding CMI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cummins Inc. (NYSE:CMI – Free Report).

Receive  News & Ratings for Cummins Daily - Enter your email address below to receive a concise daily summary of the latest  news and analysts' ratings for Cummins and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAnderson Hoagland & Co. Grows Holdings in Vanguard Mid-Cap ETF $VO

NEXT HEADLINE »iShares 0-3 Month Treasury Bond ETF $SGOV Stake Increased by Anderson Hoagland & Co.

Release Date: August 04, 2026For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Record second

Cummins Inc. (NYSE: CMI) today reported results for the second quarter of 2026.“Cummins delivered record second-quarter results, reflecting robust customer or

Cummins (CMI - Free Report) came out with quarterly earnings of $6.94 per share, missing the Zacks Consensus Estimate of $7.33 per share. This compares to earnings of $6.43 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of -5.32%. A quarter ago, it was expected that this engine maker would post earnings of $5.6 per share when it actually produced earnings of $6.15, delivering a surprise of +9.82%.

Over the last four quarters, the company has surpassed consensus EPS estimates three times.

Cummins, which belongs to the Zacks Automotive - Internal Combustion Engines industry, posted revenues of $9.46 billion for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 1.38%. This compares to year-ago revenues of $8.64 billion. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Cummins shares have added about 27.1% since the beginning of the year versus the S&P 500's gain of 11%.

What's Next for Cummins?While Cummins has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Cummins was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $8.05 on $9.66 billion in revenues for the coming quarter and $29.39 on $37.3 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Automotive - Internal Combustion Engines is currently in the top 42% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

One other stock from the broader Zacks Auto-Tires-Trucks sector, BorgWarner (BWA - Free Report) , is yet to report results for the quarter ended June 2026. The results are expected to be released on August 5.

This auto parts supplier is expected to post quarterly earnings of $1.26 per share in its upcoming report, which represents a year-over-year change of +4.1%. The consensus EPS estimate for the quarter has been revised 0.4% lower over the last 30 days to the current level.

BorgWarner's revenues are expected to be $3.58 billion, down 1.5% from the year-ago quarter.

4.8.2026 15:34, CAT, MCD, ON, PLTR

Index Dow Jones +1,28 % na 53858,23 b., S&P 500 +0,57 % na 7643,45 b., Nasdaq Composite +1,07 % na 26191,13 b.

Americké akcie v úvodu úterní seance posilují, když všechny hlavní indexy přidávají. Nejvíce se daří sektorům informačních technologií (+2,2 %), průmyslu (+0,8 %) a základních materiálů (+0,5 %). Naopak zaostávají reality (-1,5 %), energetika (-1,3 %) a nezbytná spotřeba (-1,1 %). Výsledková sezóna pokračuje v plném proudu.

Jednou ze společností, která zveřejnila své kvartální výsledky za druhé čtvrtletí roku 2026 byla softwarová společnost specializující se na datovou analýzu Palantir Technologies (PLTR). Výnosy společnosti meziročně vzrostly o 93 % na 1,94 mld. USD, což se umístilo nad odhadem analytiků 1,81 mld. USD. Společnost zároveň zvýšila celoroční výhled nad průměrný odhad analytiků. Akcie Palantir Technologies +18 %.

Výrobce čipů ON Semiconductor také reportoval hospodářské výsledky za druhé čtvrtletí roku 2026. Tržby i zisk za dané období překonaly očekávání analytiků. Analytici upozornili, že výsledky podporuje rostoucí poptávka po řešeních pro AI datacentra. Akcie ON Semiconductor +2,7 %.

Déle zveřejnil výsledky hospodaření za druhé čtvrtletí roku 2026 americký řetězec restaurací McDonald’s. Společnost vykázala 1,3% růst porovnatelných tržeb, mírně pod odhadem analytiků ve výši 1,39 %. Tržby rovněž zaostaly za očekáváním trhu, očištěný zisk na akcii však konsensus překonal. Akcie McDonald’s +0,8 %.

Výrobce stavební a těžební techniky Caterpillar rovněž zveřejnil hospodářské výsledky za druhé čtvrtletí roku 2026. Tržby i zisk na akcii překonaly odhady analytiků, přičemž segment energetiky nadále zaznamenával silný růst díky výdajům na datacentra. Společnost zároveň poprvé v historii překonala čtvrtletní tržby 20 mld. USD. Akcie Caterpillar +11 %.

Index S&P 500 +0,57 % na 7643,45 b. Nejsilnější sektory S&P Změna Nejslabší sektory S&P Změna Informační technologie +2,2 % Reality -1,5 % Průmysl +0,8 % Energie -1,3 % Základní materiály +0,5 % Nezbytná spotřeba -1,1 % Nejsilnější akcie S&P Změna Nejslabší akcie S&P Změna Zebra Technologies Corp (ZBRA) +22 % Aptiv (APTV) -15 % Palantir Technologies (PLTR) +18 % Fidelity National Information Services (FIS) -13 % Marvell Technology (MRVL) +12 % Cummins (CMI) -9,6 % Caterpillar (CAT) +11 % Rockwell Automation (ROK) -8,1 % Qnity Electronics (Q) +9,0 % WW Grainger (GWW) -7,0 %
Zdroj: Bloomberg

Marek Krejčiřík
Fio banka, a.s.
Prohlášení

Cummins raised its outlook for the year after reporting higher profit and sales in the second quarter, boosted by accelerating orders for standby power for data centers, as well as improving North American truck markets.

Posted by Defense World Staff on Aug 3rd, 2026

First Nebraska Trust Co bought a new stake in Cummins Inc. (NYSE:CMI – Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 1,308 shares of the company’s stock, valued at approximately $704,000.

Several other hedge funds also recently bought and sold shares of the company. Cedar Mountain Advisors LLC raised its stake in shares of Cummins by 1,500.0% during the 1st quarter. Cedar Mountain Advisors LLC now owns 48 shares of the company’s stock worth $26,000 after purchasing an additional 45 shares in the last quarter. Activest Wealth Management grew its stake in shares of Cummins by 537.5% in the 4th quarter. Activest Wealth Management now owns 51 shares of the company’s stock valued at $26,000 after buying an additional 43 shares in the last quarter. Wellington Shields Capital Management LLC acquired a new position in Cummins in the fourth quarter worth approximately $27,000. Key Financial Inc increased its holdings in Cummins by 62.5% in the first quarter. Key Financial Inc now owns 52 shares of the company’s stock worth $28,000 after buying an additional 20 shares during the last quarter. Finally, Birchwood Financial Partners Inc. bought a new position in Cummins during the fourth quarter valued at approximately $28,000. 83.46% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets In related news, VP Jennifer Mary Bush sold 5,000 shares of the firm’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $696.21, for a total value of $3,481,050.00. Following the transaction, the vice president directly owned 11,986 shares in the company, valued at approximately $8,344,773.06. This trade represents a 29.44% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, VP Donald G. Jackson sold 730 shares of Cummins stock in a transaction on Thursday, May 14th. The stock was sold at an average price of $710.92, for a total transaction of $518,971.60. Following the completion of the transaction, the vice president owned 8,316 shares in the company, valued at $5,912,010.72. This trade represents a 8.07% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 13,579 shares of company stock worth $9,377,684 in the last ninety days. 0.30% of the stock is owned by insiders.

Cummins Stock Up 0.2% CMI opened at $635.55 on Monday. The business has a 50 day moving average price of $670.10 and a 200 day moving average price of $622.95. Cummins Inc. has a twelve month low of $354.68 and a twelve month high of $737.76. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.11 and a current ratio of 1.71. The firm has a market cap of $87.70 billion, a P/E ratio of 32.98, a price-to-earnings-growth ratio of 1.55 and a beta of 1.24.

Cummins (NYSE:CMI – Get Free Report) last announced its earnings results on Tuesday, May 5th. The company reported $6.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.63 by $0.52. Cummins had a return on equity of 25.25% and a net margin of 7.89%.The firm had revenue of $8.40 billion during the quarter, compared to analysts’ expectations of $8.37 billion. During the same quarter in the prior year, the business earned $5.96 earnings per share. The company’s revenue was up 2.7% on a year-over-year basis. Research analysts forecast that Cummins Inc. will post 29.39 EPS for the current year.

Cummins Increases Dividend The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Friday, August 21st will be issued a dividend of $2.20 per share. The ex-dividend date of this dividend is Friday, August 21st. This represents a $8.80 annualized dividend and a dividend yield of 1.4%. This is an increase from Cummins’s previous quarterly dividend of $2.00. Cummins’s payout ratio is currently 41.52%.

Wall Street Analyst Weigh In A number of research firms have issued reports on CMI. Sanford C. Bernstein reiterated a “market perform” rating on shares of Cummins in a research note on Friday, May 22nd. Weiss Ratings lowered shares of Cummins from a “buy (b)” rating to a “buy (b-)” rating in a research note on Wednesday, May 6th. Raymond James Financial raised their price target on shares of Cummins from $675.00 to $745.00 and gave the company an “outperform” rating in a report on Tuesday, May 26th. Robert W. Baird set a $700.00 price objective on shares of Cummins in a research note on Wednesday, May 6th. Finally, Zacks Research cut shares of Cummins from a “strong-buy” rating to a “hold” rating in a report on Monday, July 13th. Eleven equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $740.07.

View Our Latest Report on Cummins

Cummins Company Profile (Free Report)

Cummins Inc (NYSE: CMI) is a global power technology company that designs, manufactures, distributes and services a broad portfolio of diesel and natural gas engines, electrified powertrains, power generation systems and related components. Founded in 1919 and headquartered in Columbus, Indiana, Cummins has grown into one of the world’s leading suppliers of internal combustion engines and a provider of technologies that reduce emissions and improve fuel efficiency.

The company’s product lineup includes heavy-, medium- and light-duty engines for on-highway and off-highway applications, generator sets and power systems for commercial and industrial use, and key engine components such as turbochargers, fuel systems, air handling, filtration and aftertreatment solutions.

Recommended Stories Five stocks we like better than Cummins 3 Fixed-Income ETFs Show Why Yield Is Only Part of the Income Story AbbVie Quietly Solved Its Biggest Problem—Now What? Rio Tinto’s Results Make the Case for Looking Beyond Tech in the AI Trade Strategy’s Structural Strength: Hidden in a $8 Billion Illusion

Receive News & Ratings for Cummins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cummins and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEGlenmede Trust Co. NA Trims Stock Position in Black Hills Corporation $BKH

Analysts on Wall Street project that Cummins (CMI - Free Report) will announce quarterly earnings of $7.33 per share in its forthcoming report, representing an increase of 14% year over year. Revenues are projected to reach $9.33 billion, increasing 7.9% from the same quarter last year.

The consensus EPS estimate for the quarter has undergone an upward revision of 1.1% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.

Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.

While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.

Given this perspective, it's time to examine the average forecasts of specific Cummins metrics that are routinely monitored and predicted by Wall Street analysts.

The average prediction of analysts places 'Net Sales- Engine- Light-duty automotive' at $531.43 million. The estimate suggests a change of +9.4% year over year.

The consensus among analysts is that 'Net Sales- Engine- Heavy-duty truck' will reach $990.73 million. The estimate points to a change of +1.5% from the year-ago quarter.

It is projected by analysts that the 'Net Sales- Engine- Medium-duty truck and bus' will reach $969.65 million. The estimate indicates a change of +2.1% from the prior-year quarter.

Analysts expect 'Net Sales- Distribution' to come in at $3.35 billion. The estimate indicates a year-over-year change of +10.3%.

The consensus estimate for 'Net Sales- Accelera' stands at $69.52 million. The estimate suggests a change of -33.8% year over year.

Based on the collective assessment of analysts, 'Net Sales- Components' should arrive at $2.79 billion. The estimate indicates a year-over-year change of +3.2%.

The combined assessment of analysts suggests that 'Net Sales- Engine' will likely reach $3.08 billion. The estimate points to a change of +6.2% from the year-ago quarter.

Analysts predict that the 'Net Sales- Engine- Off-highway' will reach $550.31 million. The estimate indicates a change of +13% from the prior-year quarter.

According to the collective judgment of analysts, 'Unit shipments - Engine - Light-duty' should come in at 44,835 . Compared to the current estimate, the company reported 44,000 in the same quarter of the previous year.

The collective assessment of analysts points to an estimated 'Unit shipments - Engine - Heavy-duty' of 29,567 . The estimate is in contrast to the year-ago figure of 29,600 .

Analysts' assessment points toward 'Unit shipments - Engine - Medium-duty' reaching 82,145 . Compared to the present estimate, the company reported 73,400 in the same quarter last year.

Analysts forecast 'Unit shipments - Engine - Total' to reach 156,547 . The estimate is in contrast to the year-ago figure of 147,000 .

View all Key Company Metrics for Cummins here>>>

Cummins shares have witnessed a change of -11.2% in the past month, in contrast to the Zacks S&P 500 composite's -1.5% move. With a Zacks Rank #3 (Hold), CMI is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

PHILADELPHIA, July 28, 2026 (GLOBE NEWSWIRE) -- CMI Media Group, WPP’s specialty healthcare agency (NYSE: WPP) and Compas, global leaders in healthcare media and technology, are proud to announce who will be speaking at this this year’s “Agility Philadelphia: Seen. Heard. Human.” Headlining the stage is legendary humanitarian Mick Ebeling, founder of Not Impossible Labs; alongside newcomers Andrew McMahon, singer-songwriter and cancer advocate; and Daniel Hulme, WPP’s Global Chief AI Officer.

Mick Ebeling returns to the Agility stage to share the latest boundary-pushing breakthroughs from Not Impossible Labs. Renowned for "Project Daniel," which pioneered 3D-printed prosthetics for war amputees, Ebeling’s work focuses on health technology, including clinical trials for tech designed to mitigate Parkinson’s disease and Alzheimer’s symptoms. Honored as one of Fortune’s "World's 50 Greatest Leaders" and recipient of the Muhammad Ali Humanitarian Award, Ebeling will challenge attendees to rethink what is possible when technology is driven by empathy. Ebeling’s TED Talks have reached millions, and his work has been featured by Fast Company, Fortune, Forbes and more. 

Making his Agility debut, RIAA-gold-certified singer-songwriter Andrew McMahon (of Jack’s Mannequin and Andrew McMahon in the Wilderness) joins the stage for an intimate session on survival, resilience and advocacy. Known for his hit song “Dark Blue,” McMahon’s life changed when he was diagnosed with acute lymphoblastic leukemia the same day he finished recording his debut album for Jack's Mannequin. His battle is captured in his documentary, “Dear Jack.” Now a survivor, McMahon will share his personal health story and discuss how his experience inspired him to found the Dear Jack Foundation, which provides critical support to adolescents and young adults diagnosed with cancer.

Also making his Agility debut, Daniel Hulme works closely with agencies to uncover, develop, and promote AI capabilities. His goal is to drive new opportunities that deliver value to both the wider organization and society as a whole. He's the CEO of Satalia, an award-winning AI company that was acquired by WPP in 2021. Hulme has been recognized as one of the world's leading keynote speakers as well as one of the top ten Chief AI Officers globally. Hulme is a contributor to numerous books, podcasts and articles on AI. His mission is to create a world where everyone has the freedom to innovate, and have those innovations become free to everyone.

Agility will take place on Monday, September 14th at the prestigious Pennsylvania Academy of the Fine Arts in Center City Philadelphia. It also aligns to the start of Fierce Pharma Week, which runs from Monday, September 14th through Thursday, September 17th at the neighboring Pennsylvania Convention Center.

"At its heart, healthcare is about humanity," said Dr. Susan Dorfman, President & CEO, CMI Media Group. "While AI and technology are deeply interwoven into our work, they are ultimately tools wielded by people to serve a higher purpose: supporting the person at the core of the story. This year's Agility event is an invitation to inspire one another and make magic happen at the intersection of technology and empathy. We hold the unique power to meet patients and caregivers right where they are—giving them the tools they need to achieve positive health outcomes and ensuring they feel truly seen, heard, and valued as humans."

"When you look at the healthcare landscape as a whole, our ultimate goal is to better serve the patient and caregiver populations in a way that feels human," said Jim Woodland, CEO, Compas. "To do that, we must leverage the power of media and technology to deliver trusted information with the accuracy, authenticity, and frequency that drives positive health outcomes. This is exactly why we are so thrilled to welcome Mick, Andrew, and Daniel to Agility. Their collective expertise will challenge our industry to elevate our communications and keep the human experience at the absolute center of our innovation.

This year's theme, “Seen. Heard. Human.” will explore how to harness the speed and creativity of consumer brand marketing, but with a profound, patient-first lens. Event programming will explore how digital agents are evolving from basic service providers into trusted caregivers. Industry leaders and clinical experts will also discuss how pharmaceutical brands can responsibly navigate this behavioral shift to build empathetic, personalized AI experiences that earn trust in a human-centered healthcare ecosystem.

Now in its fourth year, CMI Media Group and Compas’s Agility event offers a unique, non-conference style environment to ideate on the future of healthcare marketing while networking with peers and influential guests. This exclusive, invitation-only event is designed for healthcare marketing professionals; those interested in attending can request an invitation on the official event page.

About CMI Media Group 

CMI Media Group, a WPP company (NYSE: WPP, http://www.wpp.com), is a global, full-service media agency focused solely on health, wellness, and pharmaceutical marketing. CMI Media Group’s core offerings include Audience Strategy, Planning, Development, and Insights; Data and Analytics; Buying and Investment; and Direct Response and Customer Experience. As the leading media resource for the world’s top healthcare companies, CMI Media Group brings together leading technology, data, and talent to deliver seamless capabilities for clients. CMI Media Group has been recognized as a leader in inclusivity, talent retention and employee development as well as one of the industry’s best places to work. To apply for a position within our teams visit https://www.cmimediagroup.com/careers/.

About Compas

For over 35 years Compas has been partnering with the industry’s leading media providers, as well as up-and-coming innovators – representing all channels and tactics – positioning them for success with healthcare clients and agencies. As stewards of its clients’ media investments, Compas is committed to enforcing the highest standards of buying execution, effectiveness, transparency and accountability while leveraging its clients’ collective buying power through a consortium that unlocks incremental savings. Compas is certified by the National Minority Supplier Diversity Council as a minority-owned-and-operated business and generates significant Tier 1 and Tier 2 Diverse Spend. Compas has been recognized as one of the industry’s best places to work, offering industry-leading development and retention. To apply for a position within our teams visit https://compasonline.com/careers.

Contact

Carly Kuper
610-731-5409
[email protected]

Posted by Defense World Staff on Jul 26th, 2026

First Trust Advisors LP lowered its position in shares of Cummins Inc. (NYSE:CMI – Free Report) by 74.0% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 141,331 shares of the company’s stock after selling 401,465 shares during the period. First Trust Advisors LP owned approximately 0.10% of Cummins worth $76,039,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Cedar Mountain Advisors LLC grew its stake in shares of Cummins by 1,500.0% during the first quarter. Cedar Mountain Advisors LLC now owns 48 shares of the company’s stock valued at $26,000 after acquiring an additional 45 shares in the last quarter. Thompson Investment Management Inc. acquired a new position in shares of Cummins in the fourth quarter worth about $26,000. Activest Wealth Management boosted its holdings in Cummins by 537.5% in the fourth quarter. Activest Wealth Management now owns 51 shares of the company’s stock valued at $26,000 after purchasing an additional 43 shares during the last quarter. Wellington Shields Capital Management LLC purchased a new position in Cummins in the fourth quarter valued at about $27,000. Finally, Key Financial Inc grew its stake in Cummins by 62.5% during the 1st quarter. Key Financial Inc now owns 52 shares of the company’s stock valued at $28,000 after purchasing an additional 20 shares in the last quarter. 83.46% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets CMI has been the topic of several analyst reports. Weiss Ratings downgraded Cummins from a “buy (b)” rating to a “buy (b-)” rating in a report on Wednesday, May 6th. Sanford C. Bernstein reiterated a “market perform” rating on shares of Cummins in a research note on Friday, May 22nd. Raymond James Financial lifted their price target on shares of Cummins from $675.00 to $745.00 and gave the stock an “outperform” rating in a research note on Tuesday, May 26th. Argus upped their price target on shares of Cummins from $696.00 to $770.00 and gave the company a “buy” rating in a report on Monday, June 1st. Finally, UBS Group reiterated a “buy” rating on shares of Cummins in a research note on Wednesday, June 17th. Eleven analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, Cummins currently has a consensus rating of “Moderate Buy” and a consensus target price of $740.07.

Read Our Latest Report on Cummins

Insider Transactions at Cummins In other Cummins news, VP Donald G. Jackson sold 730 shares of Cummins stock in a transaction on Thursday, May 14th. The shares were sold at an average price of $710.92, for a total value of $518,971.60. Following the completion of the transaction, the vice president owned 8,316 shares of the company’s stock, valued at $5,912,010.72. The trade was a 8.07% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CAO Nicole Lamb-Hale sold 2,408 shares of the business’s stock in a transaction on Friday, May 8th. The shares were sold at an average price of $685.34, for a total transaction of $1,650,298.72. Following the sale, the chief accounting officer owned 14,084 shares of the company’s stock, valued at approximately $9,652,328.56. The trade was a 14.60% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 13,579 shares of company stock valued at $9,377,684 over the last quarter. Insiders own 0.30% of the company’s stock.

Cummins Trading Down 0.2% Shares of NYSE CMI opened at $663.96 on Friday. The company has a quick ratio of 1.11, a current ratio of 1.71 and a debt-to-equity ratio of 0.50. The stock’s 50 day moving average price is $672.19 and its two-hundred day moving average price is $619.28. Cummins Inc. has a 52-week low of $354.68 and a 52-week high of $737.76. The stock has a market capitalization of $91.62 billion, a P/E ratio of 34.46, a PEG ratio of 1.62 and a beta of 1.22.

Cummins (NYSE:CMI – Get Free Report) last issued its earnings results on Tuesday, May 5th. The company reported $6.15 EPS for the quarter, topping the consensus estimate of $5.63 by $0.52. Cummins had a return on equity of 25.25% and a net margin of 7.89%.The company had revenue of $8.40 billion during the quarter, compared to analyst estimates of $8.37 billion. During the same quarter last year, the firm earned $5.96 EPS. The business’s revenue was up 2.7% on a year-over-year basis. On average, analysts anticipate that Cummins Inc. will post 29.39 earnings per share for the current fiscal year.

Cummins Increases Dividend The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Friday, August 21st will be paid a dividend of $2.20 per share. This represents a $8.80 annualized dividend and a yield of 1.3%. This is a boost from Cummins’s previous quarterly dividend of $2.00. The ex-dividend date is Friday, August 21st. Cummins’s dividend payout ratio (DPR) is 41.52%.

Cummins Company Profile (Free Report)

Cummins Inc (NYSE: CMI) is a global power technology company that designs, manufactures, distributes and services a broad portfolio of diesel and natural gas engines, electrified powertrains, power generation systems and related components. Founded in 1919 and headquartered in Columbus, Indiana, Cummins has grown into one of the world’s leading suppliers of internal combustion engines and a provider of technologies that reduce emissions and improve fuel efficiency.

The company’s product lineup includes heavy-, medium- and light-duty engines for on-highway and off-highway applications, generator sets and power systems for commercial and industrial use, and key engine components such as turbochargers, fuel systems, air handling, filtration and aftertreatment solutions.

Featured Stories Five stocks we like better than Cummins Telecom Earnings Reveal a Sector That Finally Looks Healthier Defense Earnings Show Readiness Now and Modernization Ahead Why Palantir Investors Aren’t Panicking While the Rest of AI Sells Off MarketBeat Week in Review – 07/20- 07/24 Want to see what other hedge funds are holding CMI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cummins Inc. (NYSE:CMI – Free Report).

Receive News & Ratings for Cummins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cummins and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEDimensional Fund Advisors LP Acquires 7,254 Shares of Consolidated Edison Inc $ED

NEXT HEADLINE »ServiceNow, Inc. $NOW Shares Sold by Dimensional Fund Advisors LP

COLUMBUS, Ind.--(BUSINESS WIRE)--Cummins Inc. (NYSE: CMI) today announced updates to its Model Year 2027 North American on-highway product launch plans following its review of the U.S. Environmental Protection Agency's recently proposed changes to upcoming emissions regulations. Based on the proposed rule, Cummins intends to use the implementation flexibilities outlined by EPA to support a measured transition to its new HELM™ engine platforms. The approach is designed to maintain regulatory com.

Posted by Defense World Staff on Jul 21st, 2026

Bessemer Group Inc. grew its holdings in shares of Cummins Inc. (NYSE:CMI – Free Report) by 24.5% in the first quarter, according to its most recent filing with the SEC. The firm owned 7,975 shares of the company’s stock after acquiring an additional 1,569 shares during the quarter. Bessemer Group Inc.’s holdings in Cummins were worth $4,292,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. Juno Financial Group LLC bought a new position in Cummins during the fourth quarter valued at about $883,000. Truist Financial Corp boosted its stake in shares of Cummins by 4.8% during the 4th quarter. Truist Financial Corp now owns 64,005 shares of the company’s stock worth $32,671,000 after acquiring an additional 2,951 shares in the last quarter. Smith Salley Wealth Management boosted its stake in shares of Cummins by 1,381.8% during the 4th quarter. Smith Salley Wealth Management now owns 21,768 shares of the company’s stock worth $11,111,000 after acquiring an additional 20,299 shares in the last quarter. Westfield Capital Management Co. LP acquired a new position in shares of Cummins during the 4th quarter valued at about $7,797,000. Finally, Comprehensive Financial Consultants Institutional Inc. raised its stake in shares of Cummins by 643.0% in the 4th quarter. Comprehensive Financial Consultants Institutional Inc. now owns 7,311 shares of the company’s stock valued at $3,732,000 after acquiring an additional 6,327 shares in the last quarter. Institutional investors own 83.46% of the company’s stock.

Insiders Place Their Bets In related news, insider Brett Michael Merritt sold 701 shares of the business’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $688.75, for a total transaction of $482,813.75. Following the transaction, the insider owned 10,404 shares of the company’s stock, valued at approximately $7,165,755. The trade was a 6.31% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, VP Jennifer Mary Bush sold 5,000 shares of the company’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $696.21, for a total transaction of $3,481,050.00. Following the transaction, the vice president owned 11,986 shares of the company’s stock, valued at approximately $8,344,773.06. The trade was a 29.44% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 13,579 shares of company stock valued at $9,377,684 in the last 90 days. 0.30% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth CMI has been the subject of several analyst reports. Morgan Stanley boosted their target price on Cummins from $752.00 to $761.00 and gave the stock an “overweight” rating in a report on Friday. Argus lifted their price target on shares of Cummins from $696.00 to $770.00 and gave the company a “buy” rating in a research report on Monday, June 1st. UBS Group reissued a “buy” rating on shares of Cummins in a research report on Wednesday, June 17th. Sanford C. Bernstein restated a “market perform” rating on shares of Cummins in a research note on Friday, May 22nd. Finally, Evercore reaffirmed an “outperform” rating and set a $845.00 price objective on shares of Cummins in a report on Monday, May 11th. Eleven investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $740.07.

Check Out Our Latest Analysis on CMI

Cummins Price Performance NYSE CMI opened at $640.10 on Tuesday. The stock has a 50-day simple moving average of $675.79 and a 200 day simple moving average of $615.85. Cummins Inc. has a twelve month low of $344.02 and a twelve month high of $737.76. The stock has a market capitalization of $88.33 billion, a PE ratio of 33.22, a P/E/G ratio of 1.58 and a beta of 1.22. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.11 and a current ratio of 1.71.

Cummins (NYSE:CMI – Get Free Report) last released its earnings results on Tuesday, May 5th. The company reported $6.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.63 by $0.52. The firm had revenue of $8.40 billion for the quarter, compared to analyst estimates of $8.37 billion. Cummins had a return on equity of 25.25% and a net margin of 7.89%.The company’s revenue was up 2.7% on a year-over-year basis. During the same quarter last year, the firm posted $5.96 EPS. Research analysts anticipate that Cummins Inc. will post 29.34 EPS for the current year.

Cummins Increases Dividend The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 3rd. Stockholders of record on Friday, August 21st will be paid a $2.20 dividend. The ex-dividend date is Friday, August 21st. This is a positive change from Cummins’s previous quarterly dividend of $2.00. This represents a $8.80 annualized dividend and a dividend yield of 1.4%. Cummins’s dividend payout ratio is 45.67%.

Cummins Profile (Free Report)

Cummins Inc (NYSE: CMI) is a global power technology company that designs, manufactures, distributes and services a broad portfolio of diesel and natural gas engines, electrified powertrains, power generation systems and related components. Founded in 1919 and headquartered in Columbus, Indiana, Cummins has grown into one of the world’s leading suppliers of internal combustion engines and a provider of technologies that reduce emissions and improve fuel efficiency.

The company’s product lineup includes heavy-, medium- and light-duty engines for on-highway and off-highway applications, generator sets and power systems for commercial and industrial use, and key engine components such as turbochargers, fuel systems, air handling, filtration and aftertreatment solutions.

Further Reading Five stocks we like better than Cummins The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story Want to see what other hedge funds are holding CMI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cummins Inc. (NYSE:CMI – Free Report).

Receive News & Ratings for Cummins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cummins and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEChurchill Downs, Incorporated $CHDN Shares Purchased by Bessemer Group Inc.

NEXT HEADLINE »VeriSign, Inc. $VRSN Shares Sold by California Public Employees Retirement System

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Cummins (CMI - Free Report) . This company, which is in the Zacks Automotive - Internal Combustion Engines industry, shows potential for another earnings beat.

This engine maker has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 10.78%.

For the last reported quarter, Cummins came out with earnings of $6.15 per share versus the Zacks Consensus Estimate of $5.6 per share, representing a surprise of 9.82%. For the previous quarter, the company was expected to post earnings of $5.2 per share and it actually produced earnings of $5.81 per share, delivering a surprise of 11.73%.

Price and EPS Surprise

With this earnings history in mind, recent estimates have been moving higher for Cummins. In fact, the Zacks Earnings ESP (Expected Surprise Prediction) for the company is positive, which is a great sign of an earnings beat, especially when you combine this metric with its nice Zacks Rank.

Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better produce a positive surprise nearly 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat the consensus estimate could be as high as seven.

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Cummins currently has an Earnings ESP of +0.43%, which suggests that analysts have recently become bullish on the company's earnings prospects. This positive Earnings ESP when combined with the stock's Zacks Rank #2 (Buy) indicates that another beat is possibly around the corner. We expect the company's next earnings report to be released on August 4, 2026.

When the Earnings ESP comes up negative, investors should note that this will reduce the predictive power of the metric. But, a negative value is not indicative of a stock's earnings miss.

Many companies end up beating the consensus EPS estimate, though this is not the only reason why their shares gain. Additionally, some stocks may remain stable even if they end up missing the consensus estimate.

Because of this, it's really important to check a company's Earnings ESP ahead of its quarterly release to increase the odds of success. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.

Zacks Premium also includes the Zacks Style Scores.

What are the Zacks Style Scores? The Zacks Style Scores is a unique set of guidelines that rates stocks based on three popular investing types, and were developed as complementary indicators for the Zacks Rank. This combination helps investors choose securities with the highest chances of beating the market over the next 30 days.

Based on their value, growth, and momentum characteristics, each stock is assigned a rating of A, B, C, D, or F. The better the score, the better chance the stock will outperform; an A is better than a B, a B is better than a C, and so on.

The Style Scores are broken down into four categories:

Value ScoreValue investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and many other multiples, the Value Style Score identifies the most attractive and most discounted stocks.

Growth ScoreWhile good value is important, growth investors are more focused on a company's financial strength and health, and its future outlook. The Growth Style Score takes projected and historic earnings, sales, and cash flow into account to uncover stocks that will see long-term, sustainable growth.

Momentum ScoreMomentum trading is all about taking advantage of upward or downward trends in a stock's price or earnings outlook, and these investors live by the saying "the trend is your friend." The Momentum Style Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings estimates.

VGM ScoreIf you like to use all three kinds of investing, then the VGM Score is for you. It's a combination of all Style Scores, and is an important indicator to use with the Zacks Rank. The VGM Score rates each stock on their shared weighted styles, narrowing down the companies with the most attractive value, best growth forecast, and most promising momentum.

How Style Scores Work with the Zacks Rank The Zacks Rank is a proprietary stock-rating model that harnesses the power of earnings estimate revisions, or changes to a company's earnings expectations, to help investors build a successful portfolio.

Investors can count on the Zacks Rank's success, with #1 (Strong Buy) stocks producing an unmatched +23.94% average annual return since 1988, more than double the S&P 500's performance. But the model rates a large number of stocks, and there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.

This totals more than 800 top-rated stocks, and it can be overwhelming to try and pick the best stocks for you and your portfolio.

That's where the Style Scores come in.

You want to make sure you're buying stocks with the highest likelihood of success, and to do that, you'll need to pick stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you like a stock that only has a #3 (Hold) rank, it should also have Scores of A or B to guarantee as much upside potential as possible.

Since the Scores were created to work together with the Zacks Rank, the direction of a stock's earnings estimate revisions should be a key factor when choosing which stocks to buy.

Here's an example: a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one with Style Scores of A and B, still has a downward-trending earnings outlook, and a bigger chance its share price will decrease too.

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.

Stock to Watch: Cummins (CMI - Free Report) Cummins Inc. is a leading global designer, manufacturer and distributor of diesel and natural gas engines and powertrain-related component products. Powertrain components include fuel systems, turbochargers, transmissions, batteries and electrified power systems, among others. Headquartered in Columbus, IN, the company offers products to original equipment manufacturers (OEMs), distributors and dealers through a network of roughly 650 company-owned and independent distributor facilities in over 19,000 dealer locations in more than 190 countries and territories.

CMI is a #3 (Hold) on the Zacks Rank, with a VGM Score of B.

Additionally, the company could be a top pick for growth investors. CMI has a Growth Style Score of B, forecasting year-over-year earnings growth of 23.3% for the current fiscal year.

For fiscal 2026, six analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $1.25 to $29.33 per share. CMI boasts an average earnings surprise of +17.2%.

With a solid Zacks Rank and top-tier Growth and VGM Style Scores, CMI should be on investors' short list.

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 8th:

Cimpress (CMPR - Free Report) : This company, which is an online supplier of high-quality graphic design services and customized printed products to small businesses and consumers, has a Zacks Rank #1(Strong Buy), and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.3% over the last 60 days.

Cimpress' shares gained 23.4% over the last three month compared with the S&P 500’s gain of 10.6%. The company possesses a Momentum Score of A.

Northern Trust (NTRS - Free Report) : This company, which provides services from sovereign wealth funds to the wealthiest families, has a Zacks Rank #1, and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.5% over the last 60 days.

Northern Trust's shares gained 20.1% over the last three month compared with the S&P 500’s gain of 10.6%. The company possesses a Momentum Score of A.

Cummins (CMI - Free Report) : This company, which is a leading global designer, manufacturer and distributor of diesel and natural gas engines and powertrain-related component products, has a Zacks Rank #1, and witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.4% over the last 60 days.

Cummins' shares gained 11% over the last three month compared with the S&P 500’s gain of 10.6%. The company possesses a Momentum Score of A.

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.